NERV (Minerva Neurosciences, Inc)
Insider Trading Activity
Every open-market purchase and sale reported by NERV officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-03 | Inderjit Kaul | Director | A | — | — |
| 2026-06-05 | Inderjit Kaul | Director | A | — | — |
| 2026-06-05 | Remy Luthringer | CEO | A | — | — |
| 2026-06-05 | Frederick W Ahlholm | SVP, CFO and Secretary | A | — | — |
| 2026-06-05 | HANS PETER HASLER | Director | A | — | — |
| 2026-06-05 | G JAN VAN HEEK | Director | A | — | — |
| 2026-06-05 | Fouzia Laghrissi-Thode | Director | A | — | — |
| 2026-06-05 | David Kupfer | Director | A | — | — |
| 2026-04-22 | James Joseph O'Connor | Chief Business Officer and GC | A | — | — |
| 2026-04-01 | Inderjit Kaul | Director | A | — | — |
| 2025-12-23 | Frederick W Ahlholm | SVP, CFO and Secretary | A | — | — |
| 2025-12-23 | Inderjit Kaul | Director | A | — | — |
| 2025-12-23 | HANS PETER HASLER | Director | A | — | — |
| 2025-12-23 | Fouzia Laghrissi-Thode | Director | A | — | — |
| 2025-12-23 | Remy Luthringer | CEO | A | — | — |
| 2025-12-23 | David Kupfer | Director | A | — | — |
| 2025-12-23 | Geoff Race | President | A | — | — |
| 2025-12-23 | G JAN VAN HEEK | Director | A | — | — |
| 2025-11-18 | Inderjit Kaul | Director | A | — | — |
| 2024-12-06 | Frederick W Ahlholm | SVP, CFO and Secretary | A | — | — |
| 2024-12-06 | David Kupfer | Director | A | — | — |
| 2024-12-06 | G JAN VAN HEEK | Director | A | — | — |
| 2024-12-06 | Geoff Race | President | A | — | — |
| 2024-12-06 | Fouzia Laghrissi-Thode | Director | A | — | — |
| 2024-12-06 | HANS PETER HASLER | Director | A | — | — |
| 2024-12-06 | Remy Luthringer | CEO | A | — | — |
| 2023-10-05 | Frederick W Ahlholm | SVP, CFO and Secretary | A | — | — |
| 2023-10-05 | Remy Luthringer | CEO | A | — | — |
| 2023-10-05 | Geoff Race | President | A | — | — |
| 2023-09-29 | David Kupfer | Director | A | — | — |
| 2023-09-29 | HANS PETER HASLER | Director | A | — | — |
| 2023-09-29 | G JAN VAN HEEK | Director | A | — | — |
| 2023-09-29 | Fouzia Laghrissi-Thode | Director | A | — | — |
| 2023-09-29 | JERYL L HILLEMAN | Director | A | — | — |
| 2023-05-02 | Geoff Race | President | MIXED | — | — |
| 2023-05-02 | Frederick W Ahlholm | SVP, CFO and Secretary | MIXED | — | — |
| 2023-05-02 | Remy Luthringer | CEO | MIXED | — | — |
| 2022-12-14 | Remy Luthringer | CEO | A | — | — |
| 2022-12-14 | Frederick W Ahlholm | SVP, CFO and Secretary | A | — | — |
| 2022-12-14 | Geoff Race | President | A | — | — |
| 2022-06-28 | David Kupfer | Director | A | — | — |
| 2022-06-28 | G JAN VAN HEEK | Director | A | — | — |
| 2022-06-28 | Fouzia Laghrissi-Thode | Director | A | — | — |
| 2022-06-28 | JERYL L HILLEMAN | Director | A | — | — |
| 2022-06-28 | WILLIAM F DOYLE | Director | A | — | — |
| 2022-06-28 | HANS PETER HASLER | Director | A | — | — |
| 2022-02-18 | Frederick W Ahlholm | CFO | A | — | — |
| 2022-02-18 | Remy Luthringer | CEO | A | — | — |
| 2022-02-18 | Geoff Race | President | A | — | — |
| 2021-12-03 | David Kupfer | Director | Sell | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Director | 586,363 | — |
| — | Director | 586,363 | — |
| — | 10%+ Owner | 576,149 | — |
| — | 10%+ Owner | 562,520 | — |
| — | 10%+ Owner | 556,455 | — |
| — | 10%+ Owner | 532,085 | — |
| — | 10%+ Owner | 487,399 | — |
| — | 10%+ Owner | 427,758 | — |
| — | Director | 385,474 | — |
| — | 10%+ Owner | 207,824 | — |
| — | CEO | 184,819 | — |
| — | President | 73,406 | — |
| — | Director | 23,936 | — |
| — | SVP, CFO and Secretary | 21,098 | — |
| — | President and CEO | 5,208 | — |
| — | SVP & Chief Operating Officer | 4,372 | — |
| — | President | 4,221 | — |
| — | Director | 3,264 | — |
| — | Director | 3,125 | — |
| — | Director | 2,542 | — |
| — | Director | 1,250 | — |
| — | Director | 125 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the NERV quote page; the site-wide leaderboard is on the insider transactions hub.